• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Centers for Medicare and Medicaid Services (CMS)

CMS proposes approval of additional payment for Sequana Alfapump

April 14, 2025 By Sean Whooley

Sequana Medical announced today that CMS recommended that its Alfapump system become eligible for a new incremental payment. Alfapump treats these fluid overload conditions that arise due to liver cirrhosis and malignant ascites. The fully implantable, wirelessly charged device continuously collects ascites as it forms in the abdominal cavity. It then moves into the bladder, […]

Filed Under: Blood Management, Implants, Urology Tagged With: Centers for Medicare and Medicaid Services (CMS), Reimbursement, Sequana Medical AG

Abbott earns Medicare win for CardioMems

January 14, 2025 By Sean Whooley

An Abbott official said on social media that the company secured a significant Medicare win for its CardioMEMS platform. Keith Boettiger, VP of Abbott’s heart failure business, posted the update on LinkedIn. He said CMS granted a new national coverage determination for CardioMEMS. “This decision is a massive step forward toward increasing access to CardioMEMS […]

Filed Under: Business/Financial News, Cardiovascular, Diagnostics, Featured, News Well Tagged With: Abbott, Centers for Medicare and Medicaid Services (CMS), Reimbursement

Edwards Lifesciences scores a win at CMS for TTVR

December 23, 2024 By Danielle Kirsh

The Centers for Medicare & Medicaid Services (CMS) has announced a proposed decision to cover transcatheter tricuspid valve replacement (TTVR) for Medicare beneficiaries with severe symptomatic tricuspid regurgitation. The proposed decision would allow coverage under a Coverage with Evidence Development (CED) framework, requiring the procedure to be part of a CMS-approved clinical study to ensure […]

Filed Under: Cardiovascular, Featured, Regulatory/Compliance, Replacement Heart Valves, Structural Heart Tagged With: Abbott, Centers for Medicare and Medicaid Services (CMS), CMS, Edwards Lifesciences

AdvaMed weighs in on Dr. Oz’s selection to lead CMS

November 19, 2024 By Jim Hammerand

President-elect Donald Trump today said he is nominating Dr. Mehmet Oz to serve as administrator of the Centers for Medicare & Medicaid Services (CMS). Oz would serve under Robert F Kennedy Jr. — who Trump nominated as secretary of the U.S. Department of Health and Human Services — if Oz and Kennedy are confirmed by […]

Filed Under: Featured, News Well Tagged With: AdvaMed, Centers for Medicare and Medicaid Services (CMS), CMS, HHS, U.S. Department of Health and Human Services

Medtronic, Recor Medical score renal denervation reimbursement wins

November 5, 2024 By Danielle Kirsh

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation (RDN) technologies. Going into effect on Jan. 1, 2025, the approvals could increase patient access to the new hypertension treatments. Medtronic secured a Transitional Pass-Through (TPT) payment under the Medicare Hospital Outpatient Prospective Payment System for its Symplicity Spyral renal […]

Filed Under: Cardiovascular, Featured, Regulatory/Compliance Tagged With: Centers for Medicare and Medicaid Services (CMS), Medtronic, ReCor Medical, Reimbursement, renal denervation

CMS initiates coverage review for Abbott TriClip system

October 4, 2024 By Sean Whooley

The Centers for Medicare & Medicaid Services (CMS) accepted a formal request to provide a national coverage analysis (NCA) for the Abbott TriClip. BTIG analysts Marie Thibault and Sam Eiber say Abbott requested the NCA for its transcatheter edge-to-edge repair system for treating tricuspid valve regurgitation (T-TEER). It falls under a pilot through the Transitional […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, Medicare, Structural Heart Tagged With: Abbott, ambulatory surgery centers (ASCs), Centers for Medicare and Medicaid Services (CMS), Reimbursement

Medtronic, Recor Medical earn CMS NTAP wins for renal denervation tech

August 12, 2024 By Sean Whooley

Medtronic and Recor Medical earned a reimbursement win for their renal denervation (RDN) platforms with a new Final Rule from CMS. CMS posted its FY25 Inpatient Prospective Payment System (IPPS) Final Rule, which includes the New Technology Add-on Payment (NTAP) program. NTAP supports access for newly approved, innovative technologies where the cost to adopt may […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured, Medicare, Vascular Tagged With: ambulatory surgery centers (ASCs), Centers for Medicare and Medicaid Services (CMS), Medtronic, ReCor Medical

CVRx earns Medicare win for Barostim procedure

August 2, 2024 By Sean Whooley

CVRx (Nasdaq:CVRX) announced today that the Centers for Medicare and Medicaid Services (CMS) reassigned its Barostim implant procedure. CMS reassigned Barostim for the inpatient setting as part of the Fiscal Year (FY) 2025 Medicare Hospital Inpatient Prospective Payment System (IPPS) final rule. In FY 2024, CMS assigned Barostim to MS-DRGs 252, 253, 254. That had […]

Filed Under: Business/Financial News, Cardiovascular, Implants, Medicare, Neurological, Neuromodulation/Neurostimulation Tagged With: Centers for Medicare and Medicaid Services (CMS), cvrx, CVRx Inc., Reimbursement

Cala names new CEO, earns Medicare coverage for TAPS therapy

June 10, 2024 By Sean Whooley

Cala announced today that it picked a new CEO as its TAPS therapy for essential tremor (ET) received Medicare coverage. The company promoted current Chief Product Officer Deanna Harshbarger to the corner office, effective immediately. She also becomes a member of the company’s board of directors. Renee Ryan, who became CEO at Cala in 2019, […]

Filed Under: Business/Financial News, Featured, Health Technology, Medicare, Neurological, Neuromodulation/Neurostimulation Tagged With: Cala Health, Centers for Medicare and Medicaid Services (CMS), Personnel Moves

Ekso Bionics earns Medicare win for exoskeleton tech

December 13, 2023 By Sean Whooley

Ekso Bionics (Nasdaq:EKSO) announced that the Centers for Medicare & Medicaid Services (CMS) proposed a payment level for its exoskeleton. The Pricing, Data Analysis, and Coding (PDAC) contractor completed its review of the Ekso Indego Personal, approving the use of Healthcare Common Procedure Coding System (HCPCS) Code K1007 to bill Medicare for the device. CMS […]

Filed Under: Business/Financial News, Medicare, News Well, Prosthetics Tagged With: Centers for Medicare and Medicaid Services (CMS), Ekso Bionics

CVRx scores Medicare win on outpatient Barostim payments

November 3, 2023 By Sean Whooley

CVRx (Nasdaq:CVRX) announced today that the Centers for Medicare and Medicaid Services (CMS) reassigned its Barostim implant procedure. The CMS change assigns the CVRx neuromodulation implant for procedures performed in the outpatient setting. It comes as part of the 2024 Medicare Hospital Outpatient Prospective Payment System (OPPS) final rule. Barostim’s reassignment brings it to New Technology […]

Filed Under: Business/Financial News, Cardiovascular, Implants, Medicare, Neurological, Neuromodulation/Neurostimulation, Regulatory/Compliance Tagged With: Centers for Medicare and Medicaid Services (CMS), CMS, CVRx Inc.

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 43
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy